Type 1 diabetes: Diagnosis and management of type 1 diabetes in children, young people and adults
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/cg15
Changes since publication
Since the publication of this guideline some of the recommendations have been updated in other NICE guidance, or by changes in guidance from other organisations.
-
October 2011: Recommendations on managing hyperglycaemia in inpatients with threatened or actual myocardial infarction have been updated in line with 'Hyperglycaemia in acute coronary syndromes: management of hyperglycaemia in people with acute coronary syndromes' (NICE clinical guideline 130). Recommendation 1.12.3.6 – we have removed the recommendation that optimal insulin therapy should be provided to adults with diabetes who have threatened or actual myocardial infarction
-
March 2010: Recommendations on neuropathic pain(recommendations 1.11.5.2, 1.11.5.3, 1.11.5.4, 1.11.5.5 and 1.11.5.7) have been updated and replaced by 'Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings' (NICE clinical guideline 96, published March 2010).
-
June 2009: Recommendations on serological testing for coeliac disease have been updated in line with 'Coeliac disease: recognition and assessment of coeliac disease' (NICE clinical guideline 86, published May 2009):
-
Recommendation 1.3.5.1 – we have removed the recommendation to re-test for coeliac disease at least every 3 years after diagnosis.
-
Recommendation 1.12.4.1 – this now recommends that adults with type 1 diabetes should have serological testing for coeliac disease.
-
-
Recommendations on insulin pumps NICE has published more recent guidance on insulin pumps – 'Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus' (NICE technology appraisal guidance 151).
Other changes
-
23 December 2011: minor maintenance.
-
The British Society for Paediatric Endocrinology and Diabetes has published an updated guideline on ketoacidosis in children and young people (referred to in recommendation 1.3.2.1 and appendix F). We have deleted appendix F and added the link to the updated guideline.
-
The World Health Organization has produced new guidance on diagnosing diabetes (referred to in recommendation 1.1.1.1). We have added the link to the updated guidance.
-
'Hypostop' (referred to in recommendation 1.3.1.5) is now known as 'Glucogel'. We have updated the name of this product in recommendation 1.3.1.5.